Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure

Emerging concepts in arrhythmogenic dilated cardiomyopathy

(2020) Thomas Zegkos et al.   HEART FAILURE REVIEWS

Impact of wearable cardioverter‐defibrillator compliance on outcomes in the VEST trial: As‐treated and per‐protocol analyses

(2020) Jeffrey E. Olgin et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

(2020) Paul W. Armstrong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system

(2020) Milo Gatti et al.   European Journal of Preventive Cardiology

The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator

(2020) Vincenzo Russo et al.   Journal of Clinical Medicine

Prevention: From the cradle to the grave and beyond

(2019) Paul Dendale et al.   European Journal of Preventive Cardiology

Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction

(2019) Pieter Martens et al.   Clinical Research in Cardiology

Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long‐Term Registry: bridging between EMA/FDA label, the PARADIGM‐HF trial, ESC Guidelines, and real‐world

(2019) Chris J. Kapelios et al.   EUROPEAN JOURNAL OF HEART FAILURE

Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology

(2019) Petar M. Seferovic et al.   EUROPEAN JOURNAL OF HEART FAILURE

Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator

(2019) Milton Packer   Circulation-Arrhythmia and Electrophysiology

Effects of the Angiotensin‐Receptor Neprilysin Inhibitor on Cardiac Reverse Remodeling: Meta‐Analysis

(2019) Yiwen Wang et al.   Journal of the American Heart Association

Association Between Use of Primary Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients with Heart Failure: A Prospective Propensity-Score Matched Analysis from the Swedish Heart Failure Registry

(2019) Benedikt Schrage et al.   CIRCULATION

What causes sudden death in patients with chronic heart failure and a reduced ejection fraction?

(2019) Milton Packer   EUROPEAN HEART JOURNAL

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

(2019) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sacubitril-valsartan versus enalapril for acute decompensated heart failure: a cost-effectiveness analysis

(2019) Kanila Perera et al.   European Journal of Preventive Cardiology

Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications

(2019) Elisa Dal Canto et al.   European Journal of Preventive Cardiology

The relationship between baseline and follow-up left ventricular ejection fraction with adverse events among primary prevention ICD patients

(2018) Daniel J. Friedman et al.   AMERICAN HEART JOURNAL

Ventricular Arrhythmic Storm after Initiating Sacubitril/Valsartan

(2018) Lourdes Vicent et al.   CARDIOLOGY

European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS)

(2018) Giuseppe Boriani et al.   EUROPACE

Pharmacological treatments for heart failure with preserved ejection fraction—a systematic review and indirect comparison

(2018) Kwadwo Osei Bonsu et al.   HEART FAILURE REVIEWS

Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices

(2018) Carlos de Diego et al.   HEART RHYTHM

Cardiac resynchronization therapy: How did consensus guidelines from Europe and the United States evolve in the last 15 years?

(2018) Giuseppe Boriani et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Impaired Recovery of Left Ventricular Function in Patients With Cardiomyopathy and Left Bundle Branch Block

(2018) Edward Sze et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?

(2018) Axel Sarrias et al.   CIRCULATION

Wearable Cardioverter–Defibrillator after Myocardial Infarction

(2018) Jeffrey E. Olgin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews

(2018) Muaamar Al-Gobari et al.   BMJ Open

Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes

(2018) Giuseppe Boriani et al.   Nucleus

Risk stratification of cardiovascular and heart failure hospitalizations using integrated device diagnostics in patients with a cardiac resynchronization therapy defibrillator

(2017) Haran Burri et al.   EUROPACE

Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD)

(2017) Federico Guerra et al.   EUROPACE

Extending survival by reducing sudden death with implantable cardioverter-defibrillators: a challenging clinical issue in non-ischaemic and ischaemic cardiomyopathies

(2017) Giuseppe Boriani et al.   EUROPEAN JOURNAL OF HEART FAILURE

Patient outcome after implant of a cardioverter defibrillator in the ‘real world’: the key role of co-morbidities

(2017) Giuseppe Boriani et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effectiveness of a management program for outpatient clinic or remote titration of beta-blockers in CRT patients: The RESTORE study

(2017) Antonio D'Onofrio et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Defibrillation for Ventricular Fibrillation

(2017) Graham Nichol et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Multisensor Algorithm Predicts Heart Failure Events in Patients With Implanted Devices

(2017) John P. Boehmer et al.   JACC-Heart Failure

Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction

(2017) Selcuk Adabag et al.   JAMA Cardiology

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

(2016) Scott A. Hubers et al.   CIRCULATION

Effects of Sacubitril/Valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) According to Background TherapyCLINICAL PERSPECTIVE

(2016) Naoki Okumura et al.   Circulation-Heart Failure

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: a meta-analysis of randomized controlled trials in patients with heart failure

(2016) Catherine Klersy et al.   EUROPEAN JOURNAL OF HEART FAILURE

Cardiac device therapy in patients with left ventricular dysfunction and heart failure: ‘real-world’ data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital)

(2016) Giuseppe Boriani et al.   EUROPEAN JOURNAL OF HEART FAILURE

Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD)

(2016) Federico Guerra et al.   HEART RHYTHM

Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation

(2016) Gregory A. Roth et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

(2016) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

2016 European Guidelines on cardiovascular disease prevention in clinical practice

(2016) et al.   European Journal of Preventive Cardiology

Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac PatientsCLINICAL PERSPECTIVE

(2015) Valentina Kutyifa et al.   CIRCULATION

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

(2015) Silvia G. Priori et al.   EUROPEAN HEART JOURNAL

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients

(2015) Akshay S. Desai et al.   EUROPEAN HEART JOURNAL

Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients

(2015) Yiyi Zhang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevalence of Guideline-Directed Medical Therapy Among Patients Receiving Cardiac Resynchronization Therapy Defibrillator Implantation in the National Cardiovascular Data Registry During the Years 2006 to 2008

(2014) Preston M. Schneider et al.   AMERICAN JOURNAL OF CARDIOLOGY

Awareness of indications for device therapy among a broad range of physicians: a survey study

(2014) Clara Hübinette et al.   EUROPACE

Electrical storm and heart failure worsening in implantable cardiac defibrillator patients

(2014) F. Guerra et al.   EUROPACE

20 Years of Cardiac Resynchronization Therapy

(2014) Francisco Leyva et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials

(2013) Muaamar Al-Gobari et al.   BMC Cardiovascular Disorders

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)

(2013) et al.   EUROPACE

Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction

(2013) Anne B. Curtis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex

(2013) Frank Ruschitzka et al.   NEW ENGLAND JOURNAL OF MEDICINE

How Can Optimization of Medical Treatment Avoid Unnecessary Implantable Cardioverter-Defibrillator Implantations in Patients With Idiopathic Dilated Cardiomyopathy Presenting With “SCD-HeFT Criteria?”

(2011) Massimo Zecchin et al.   AMERICAN JOURNAL OF CARDIOLOGY

Management of patients receiving implantable cardiac defibrillator shocks: Recommendations for acute and long-term patient management

(2010) F. Braunschweig et al.   EUROPACE

Role of drugs and devices in patients at risk of sudden cardiac death

(2010) Giuseppe Boriani et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

(2010) Karl Swedberg et al.   LANCET

Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

(2010) Anthony S.L. Tang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Prognosis After Cardiac Resynchronization Therapy Is Related to the Extent of Left Ventricular Reverse Remodeling at Midterm Follow-Up

(2009) Claudia Ypenburg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Defibrillator Implantation Early after Myocardial Infarction

(2009) Gerhard Steinbeck et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

(2009) Arthur J. Moss et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms

(2008) Cecilia Linde et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure

(2008) Jeanne E. Poole et al.   NEW ENGLAND JOURNAL OF MEDICINE